FIELD: medicine, pharmaceutics.
SUBSTANCE: what is presented is a therapeutic agent for treating oestrogen-dependent cancer. The presented agent contains (-)-secoisolariciresinol and additives: starch, talcum and magnesium strarate. What is shown is that: the declared agent promotes a considerable inhibition of the mammary adenocarcinoma growth with no side effects (nausea and vomiting) observed.
EFFECT: presented therapeutic agent possesses high biological activity; it is safe for the patient, readily producible, and easy to use.
1 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| BIOLOGICALLY ACTIVE SUPPLEMENT TO FOOD BASED ON VEGETABLE COMPONENTS FOR PROPHYLAXIS OF PATHOLOGICAL SYMPTOMS OF CLIMACTERIC SYNDROME | 2000 |
|
RU2197975C2 |
| DIINDOLYLMETHANE SOLID MEDICINAL FORMULATION FOR TREATMENT OF NEOPLASTIC DISEASE | 2006 |
|
RU2318509C2 |
| ANTICANCER DRUG FOR ORAL USE | 2020 |
|
RU2748989C1 |
| HYDROXYMATAIRESINOL IN PREVENTING THE CANCER | 2000 |
|
RU2241453C2 |
| PHARMACEUTICAL COMPOSITION FOR TREATING MALIGNANT GROWTHS OF PROSTATE GLANDS | 2015 |
|
RU2589266C1 |
| MEDICINAL AGENT FOR CANCER PREVENTION | 2006 |
|
RU2328294C1 |
| USING SECOISOLARICIRESINOL AS HAEMORHEOLOGICAL, ANTI-PLATELET AND ENDOTHELIUM-PROTECTIVE AGENT | 2013 |
|
RU2532356C1 |
| FRUIT-AND-BERRY FOOD PRODUCT WITH ANTI-MICROBIAL EFFECT AGAINST HELICOBACTER PYLORI | 2010 |
|
RU2523009C2 |
| AGENT FOR TREATING HORMONE-DEPENDENT TUMORS AND A METHOD FOR PRODUCTION THEREOF | 2018 |
|
RU2703533C1 |
| GAMMA-SCHIZADRIN SYNTHESIS METHOD | 2009 |
|
RU2401122C1 |
